Thermo Fisher Scientific buys European diagnostics firm for $2.6B
The company is acquiring The Binding Site Group from private equity firm Nordic Capital.
Stay updated with breaking news from Binding Site Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company is acquiring The Binding Site Group from private equity firm Nordic Capital.
Once acquired, the Birmingham, UK-based blood cancer and immune disease diagnostics company will become part of Thermo Fisher's specialty diagnostics segment.
Once acquired, the Birmingham, UK-based blood cancer and immune disease diagnostics company will become part of Thermo Fisher's specialty diagnostics segment.
Thermo Fisher Scientific (NYSE:TMO) announced today that it entered into a definitive agreement to acquire The Binding Site Group.
Immunoassay Analyzers Market – 2021 Trends, Growth Insight, Size, Share, Competitive Analysis, Statistics, Regional, And Global Forecast To 2023